Table 2

Gene expression changes reported previously

    Expression Level (% of Naïve Control)


    Gene Name

    Gene ID

    Nv1

    Nv10

    Nv100


mPFC

Activity-related cytoskeleton-associated protein

Arc

43.9 ± 14**

76.8 ± 12

51.8 ± 10**


Cocaine and amphetamine regulated transcript

CART

725.2 ± 130**

191.9 ± 55

190.3 ± 86


Early growth response 1

Erg1

59.6 ± 9.2*

74.7 ± 15

74.5 ± 5.3


FBJ osteosarcoma oncogene

Fos

41.7 ± 12**

58.1 ± 11**

53.1 ± 6.8**


Neuropeptide Y

Npy

158.4 ± 21#

94.5 ± 9.5

91 ± 5.2


Nuclear receptor subfamily 4, group A, member 1

Nr4a1

35.1 ± 11**

53.4 ± 12*

49.4 ± 7.7*


NAc

Activity-related cytoskeleton-associated protein

Arc

83.5 ± 22

73.7 ± 12

49.5 ± 6.4*


FBJ osteosarcoma oncogene

Fos

53.9 ± 16**

60.3 ± 6.7**

51.7 ± 62**


Nuclear receptor subfamily 4, group A, member 1

Nr4a1

65.7 ± 20

63.4 ± 11

48.1 ± 5.1*


Data is presented as mean ± standard error of the mean (SEM), ANOVA with Student-Newman-Keuls post hoc testing; * p < 0.05, ** p < 0.01, # p < 0.001. Data previously reported in [12].

Freeman et al. BMC Neuroscience 2010 11:29   doi:10.1186/1471-2202-11-29

Open Data